Social Media Influencers Fueling Unofficial Market for Unapproved Slimming Drug
A shadow economy for unapproved slimming drugs is propelled by social media fitness personalities and vendors on communication apps, according to recent findings.
Experimental Treatment Gaining Traction Online
Retatrutide, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Followers are encouraged to message these accounts directly for supplier links, while also obtaining promotional offers.
Active Trade on Social Networks
Additionally, a flourishing trade exists on Telegram, where groups with numerous of members share “before and after” images, injection guides and assertions of next-day British shipping. Sellers promote the drug there before redirecting customers to WhatsApp for purchases.
Learning About The Experimental Drug
Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.
Healthcare Experts Voice Concerns
However, doctors and chemists have warned that the distribution of what is still an unapproved medication in the UK is a cause for concern and could result in users administering products of unknown origin.
Several experts said the demand for the experimental drug could be connected to the increasing cost of approved slimming products such as Mounjaro.
Legal Position and Enforcement
Marketing the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unapproved medication that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.
Some influencers attempt to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate medicines, marketing, and customer laws, risking penalties, prosecution or imprisonment.
Service Response and Content Removal
According to TikTok, the platform has removed problematic content and banned associated keywords and query recommendations. The company said it was committed to keeping the service secure and investing in strengthening compliance measures.
Online Trading Activities
Research also found communities with up to 9,000 participants marketing the experimental drug using the platform's built-in discovery tool, which functions like a public directory. Typing “retatrutide” immediately displays groups with thousands of members, populated with images of slimming results, glowing testimonials and detailed instructions for preparing or injecting at residence.
Within minutes of entering one community, a vendor shared WhatsApp details, where most transactions occur. The seller sent an guidebook and guaranteed shipping within two days. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None inquired about body mass, health issues or previous experience.
Product Details and Pricing
Within these groups, posts display dark colored packages with Royal Mail labels, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at home with sterile water, or ready-to-use pens typically sold at £160 for 20 milligrams. When questioned how much time a pen should be used, vendors give conflicting answers varying between a few weeks to “depends on your body”.
Platform Moderation and Safety Measures
A spokesperson for the messaging service said it regularly monitored dangerous material on its platform including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are administering materials they cannot confirm. Even if the science behind this drug is sound, these online products may not include what they claim,” said Jason Murphy, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the surge in demand to recent price rises for approved weight-loss drugs such as Mounjaro. “With costs rising, patients are using social media. But counterfeit injections are extremely risky. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she explained.
Her team has already encountered individuals harmed by personal administration from unconfirmed sources. “We understand the frustration, but buying from Telegram or communication platforms is taking chances with your well-being,” stated the doctor. “These materials could be impure or incorrectly dosed.”
Manufacturer Position
A spokesperson from Eli Lilly said retatrutide was in phase 3 research studies and had not been reviewed or approved by any regulatory agency globally. “Consequently at this point no one can market [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a company investigational substance not yet approved … may expose users to possibly significant medical dangers”.
